2 stories tagged #mirvetuximab soravtansine

  1. NHS Greenlights Revolutionary Ovarian Cancer Drug After Two-Decade Hiatus
    health

    NHS Greenlights Revolutionary Ovarian Cancer Drug After Two-Decade Hiatus

    NHS approves AbbVie's targeted therapy mirvetuximab soravtansine for platinum resistant ovarian cancer, extending survival and marking the first new treatment in 20 years.

    32m ago 1 min read
  2. NHS Approves New ‘Trojan Horse’ Drug for Ovarian Cancer
    health

    NHS Approves New ‘Trojan Horse’ Drug for Ovarian Cancer

    NHS approves mirvetuximab soravtansine, a targeted therapy extending survival for hard-to-treat ovarian cancer patients.

    2h ago 1 min read